Skip to main content
AGX
NYSE Real Estate & Construction

CEO Sells $8.4M in Argan Stock Following Option Exercise Amidst Broader Insider Distribution

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$651.68
Mkt Cap
$9.088B
52W Low
$130.35
52W High
$651.99
Market data snapshot near publication time

Summary

Argan's subsidiary CEO, Charles Edwin IV, sold $8.4 million in common stock after exercising options, adding to a trend of insider selling near the company's 52-week high.


Key Events

  • CEO Sells Significant Shares

    Charles Edwin IV, CEO of GEMMA (an Argan subsidiary), sold 13,568 shares of Argan common stock for a total value of $8,404,979.48 through open market transactions on April 20-21, 2026.

  • Option Exercise Precedes Sale

    The sale followed the exercise of options to acquire 13,568 shares, with an aggregate exercise cost of $539,704.11, indicating a monetization event.

  • Part of Broader Insider Distribution

    This transaction is consistent with a recent trend of insider selling at Argan, with over $30 million in net insider sales reported in the last 90 days, including a $11.6 million sale by the President and CEO on April 20, 2026.

  • Stock Trading Near 52-Week High

    The insider selling activity occurs while Argan's stock is trading near its 52-week high of $651.99, potentially indicating executives are locking in gains.


Analysis

Charles Edwin IV, CEO of Argan's subsidiary GEMMA, sold over $8.4 million worth of common stock after exercising options. This transaction, occurring while the stock trades near its 52-week high, contributes to a notable pattern of insider selling at Argan, which has seen over $30 million in net insider sales in the last 90 days. Investors should note this continued distribution by key executives, as it may signal a lack of conviction at current price levels despite the company's strong recent financial performance.

At the time of this filing, AGX was trading at $651.68 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9.1B. The 52-week trading range was $130.35 to $651.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AGX - Latest Insights

AGX
Jun 04, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $708.00
Real-time Price: $647.26 info
Change: -$60.74 (-9%) info
Market Cap: $9.074B info
AGX
Jun 04, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $689.43
Real-time Price: $647.26 info
Change: -$42.17 (-6%) info
Market Cap: $9.074B info
AGX
Jun 04, 2026, 4:06 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $691.49
Real-time Price: $647.26 info
Change: -$44.23 (-6%) info
Market Cap: $9.074B info
AGX
Apr 23, 2026, 1:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $658.53
Real-time Price: $647.26 info
Change: -$11.27 (-2%) info
Market Cap: $9.074B info
AGX
Apr 22, 2026, 5:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $651.68
Real-time Price: $647.26 info
Change: -$4.42 (-0.68%) info
Market Cap: $9.074B info
AGX
Apr 20, 2026, 5:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $611.21
Real-time Price: $647.26 info
Change: +$36.05 (+6%) info
Market Cap: $9.074B info
AGX
Apr 17, 2026, 9:55 AM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $607.80
Real-time Price: $647.26 info
Change: +$39.46 (+6%) info
Market Cap: $9.074B info
AGX
Apr 17, 2026, 9:50 AM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $606.95
Real-time Price: $647.26 info
Change: +$40.31 (+7%) info
Market Cap: $9.074B info
AGX
Apr 08, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $588.28
Real-time Price: $647.26 info
Change: +$58.98 (+10%) info
Market Cap: $9.074B info
AGX
Apr 08, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $588.28
Real-time Price: $647.26 info
Change: +$58.98 (+10%) info
Market Cap: $9.074B info